WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

THERAPEUTIC STUDY OF MUSABBAR (ALOE) IN THE MANAGEMENT OF KASHTARTAVA W.S.R. TO DYSMENORRHOEA

Dr. Dhiman Sonia*, Kumar Ajay, Dhiman Monika and Vishwakarma Kumar Santosh

ABSTRACT

Musabbar (Aloe barbadensis Miller’s extract) is maketed as Elua, musabbar, ghikuwara rasa. Musabbar, Eliyaka, Krishnabola, Virasrava, Sahasara, Kumarirassambhava and Kanyasara, Kumarisara are its various synonyms. Musabbar is an ingredient of formulations named as Vijyadi vati and Rajah pravartani vati which are mentioned to treat Kashtartava in Bhaishjyaratnavali. Kashtartava is the disease where Artava is shaded with great difficulty and pain. It is correlated with the term Dysmenorrhoea which is defined as painful menstruation of sufficient magnitude so as to incapacitate day to day activities. Totals 15 patient of kashtartava (dysmenorrhoea) were studied clinically with musabbar capsules (500mg each) given TID for six menstrual cycles. Results of pain intensity were extremely significant statistically (t=12.43) with percentage relief 71.06%, duration of pain were significant (t=3.16) with percentage relief 54.18%. Amount of flow was increased by 50%. Drug also showed significant results in associated symptoms like nausea, breast tenderness, giddiness, anorexia and irritability. Hence this single drug is efficacious as a line of treatment for Kashtartava (dysmenorrhoea).

Keywords: Kashtartava, dysmenorrhoea, Musabbar.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More